Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/1/26 20:13 | 9/29/26 | HELP | Health | Drug | Pharmaceutical Preparations | Cavers Greg | O | CFO | 1 | P | 39 | 12.91 | 0 | 3 | 2 | 129 | I | |||||||||||||||
9/21/26 17:07 | 9/21/26 | CYBN | Health | Drug | Pharmaceutical Preparations | Halstead Michael | O | CEO | 1 | P | 1,347 | 13.47 | 0 | 100 | 146 | 169 | D | |||||||||||||||
9/11/26 09:04 | 9/8/26 | CYBN | Health | Drug | Pharmaceutical Preparations | Glavine Paul | O | Chief Gr | 4 | P | 4,715 | 12.09 | 0 | 390 | 9 | 4,502 | D | |||||||||||||||
9/11/26 09:01 | 9/8/26 | CYBN | Health | Drug | Pharmaceutical Preparations | So Eric H. L. | DO | Exec Cha | 3 | P | 3,569 | 12.10 | 0 | 295 | 7 | 4,519 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |